Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: SVY, PLW

USIJ Releases Report on The Importance of an Effective and Reliable Patent System to Critical Technologies


WASHINGTON, Aug. 3, 2020 /PRNewswire/ -- Today, the Alliance of U.S. Startups and Inventors for Jobs (USIJ) released The Importance of an Effective and Reliable Patent System to Investment in Critical Technologies, a report studying recent trends in venture capital investment in patent-intensive industries. It was authored by Professor Mark Schultz, Goodyear Tire & Rubber Company Endowed Chair in Intellectual Property Law and Director, Intellectual Property and Technology Law Program at the University of Akron. 

Analyzing data on U.S. venture capital investment from 2004 to 2017, the report finds that the share of investment going to patent intensive industries has declined significantly. To better understand these trends, Professor Schultz conducted interviews with innovators, investors, and executives who have served in leading institutions such as New Enterprise Associates, Juno Therapeutics, the Cleveland Clinic, and Convelo Therapeutics. These case studies suggest that recent changes to the patent system were a key contributor in investment flowing away from patent-intensive startups in sectors critical to U.S. national security and public safety, such as pharmaceuticals, biotech, and semiconductors.

USIJ Executive Director Chris Israel issued the following statement:

"USIJ is pleased to release this timely report studying the troublesome trends in VC investment in patent-intensive industries. The important role of innovation to our national security and public safety has perhaps never been more evident than in current efforts to fight COVID-19. The report raises serious concerns about how recent changes to weaken the patent system has had a direct and significant impact on funding decisions made by U.S. venture capitalists.

In the coming months, USIJ will lead a series of discussions with legal, policy, and industry experts to develop a set of policy recommendations to address the shortfalls in our patent system. We look forward to working with leaders in Congress and the Administration to restore balance to our patent system so it once again incentives investments in the breakthrough technologies that will prove essential to fighting the pandemic and for decades to come."

About the USIJ:
USIJ is a group of nearly 30 startups, inventors, investors, and entrepreneurs. Collectively, we have launched dozens of companies in areas including biotechnology, clean energy, medical devices and wireless technology. We invent real things and create real companies. We also rely on the strength of the U.S. patent system to create these companies, breakthroughs, and jobs.

Press Contact:
Chris Israel, USIJ
(202) 327-8100
[email protected]

SOURCE USIJ


These press releases may also interest you

at 11:50
The "Global Live Events Market (2024 Edition): Analysis By Event Type (Music, Sports, Comedy, and Theater), By Revenue Source, By Age Group, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to...

at 11:31
The FLCCC Alliance today announced Lynne Kristensen will step into the newly created senior director, communications role leading global public relations and media strategy for the organization. She will also oversee the FLCCC's new international...

at 11:30
The OLB Group, Inc., , a diversified Fintech eCommerce merchant services provider and cryptocurrency mining enterprise, announced today that it has received a written letter from Nasdaq, which has determined that for the last 10 consecutive business...

at 10:50
The "India Embedded Finance Business and Investment Opportunities Databook - 75+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. Embedded Finance...

at 09:55
Egon Zehnder, the world's preeminent leadership advisory firm, today announced Francesco Buquicchio as its next CEO. Buquicchio succeeds Edilson Camara, following a strategic leadership transition and succession planning process. Camara, who will...

at 09:30
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Atara...



News published on and distributed by: